← Back to Search

Aerosol Reduction Techniques for Dental Clinics

N/A
Recruiting
Led By Khaled Altabtbaei
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during procedure
Awards & highlights

Study Summary

This trial looks at 4 ways to cut down on dental aerosol (germ) spread during orthodontic work.

Who is the study for?
This trial is for patients undergoing orthodontic debonding who agree to provide saliva and nasal samples. It's not suitable for those allergic to Povidone-Iodine or Chlorhexidine, or anyone unwilling to participate.Check my eligibility
What is being tested?
The study tests four methods aimed at reducing bioaerosol spread in dental clinics: Chlorhexidine mouthwash, Povidone-Iodine, high volume evacuator tools alone or with a saliva ejector, and local exhaust systems.See study design
What are the potential side effects?
Potential side effects may include reactions to the mouthwashes used such as taste alteration, staining of teeth, or irritation inside the mouth. Equipment like evacuators might cause discomfort.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and during procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Bioaerosol measurement from the tracked sources
Mass concentration measurements across the 4 different types of interventions
Particle concentration measurements across the 4 different types of interventions
Secondary outcome measures
Bacterial contamination on the inside surface of the mask of operators and assistants

Trial Design

1Treatment groups
Experimental Treatment
Group I: Orthodontic debondingExperimental Treatment4 Interventions

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
886 Previous Clinical Trials
384,738 Total Patients Enrolled
Khaled AltabtbaeiPrincipal InvestigatorUniversity of Alberta

Media Library

Chlorhexidine mouthwash and Povidone-Iodine Clinical Trial Eligibility Overview. Trial Name: NCT05468099 — N/A
Chlorhexidine mouthwash and Povidone-Iodine 2023 Treatment Timeline for Medical Study. Trial Name: NCT05468099 — N/A
Risk Reduction Research Study Groups: Orthodontic debonding
Risk Reduction Clinical Trial 2023: Chlorhexidine mouthwash and Povidone-Iodine Highlights & Side Effects. Trial Name: NCT05468099 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have been recruited for this clinical experiment?

"Correct. Data hosted on clinicaltrials.gov displays that this medical study, which was initialised on March 29th 2022, is actively seeking out potential candidates. Approximately 40 patients need to be identified from 1 research site."

Answered by AI

Is this experimentation actively seeking participants at present?

"According to the clinicaltrials.gov database, this research is actively recruiting participants as of July 19th 2022; it was originally posted on March 29th 2022."

Answered by AI
~13 spots leftby Apr 2025